{
 "PrintNo":"S8190","Session":2021,"Chamber":"SENATE","BillType":"Senate","Published":"2022-02-01T12:46:49.869591Z",
 "Status":"IN_SENATE_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2022-02-01","Committee":"Health"}],
 "Actions":[{"Text":"REFERRED TO HEALTH","Date":"2022-02-01","Chamber":"SENATE"}],
 "Sponsors":[{"ID":914,"Name":"Roxanne J. Persaud","Short":"PERSAUD"},{"ID":438,"Name":"Brad Hoylman-Sigal","Short":"HOYLMAN"}],
 "Title":"Requires clinical trials that apply for state grant funding to make certain information about such clinical trials public",
 "Summary":"Requires any sponsor of a clinical trial in this state, including but not limited to, a pharmaceutical drug manufacturer, pharmaceutical drug wholesaler, academic medical center, voluntary group, federal agency or health care provider, that applies for a state grant to conduct such clinical trial, to conspicuously post certain information about such clinical trial on the department's website.",
 "LawSection":"Public Health Law","LawCode":"Add Art 2 Title 8 §§269 - 269-b, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to requiring clinical trials that apply for state grant funding to make certain information about such clinical trials public",
 "SameAsPrintNo":"A9331-2021"
}